Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

JRNYS vs Vitalex Health

JRNYS
Graded #267

Higher grade

vs+2.799999999999997
Vitalex Health
Graded #337

Lower grade

The verdict

JRNYS takes it — 62.5/100 to 59.7/100.

JRNYS grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. JRNYS is a telehealth weight-loss membership built around branded GLP-1 medications, and the membership itself buys no medication.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueVitalex Health +9
45
54
Dose & formulationVitalex Health +6
58
64
Clinical oversightJRNYS +20
84
64
Labs & monitoringJRNYS +19
71
52
FulfillmentVitalex Health +5
65
70
Contract termsEven
55
55
JRNYS · left barVitalex Health · right bar

The numbers

MetricJRNYSVitalex Health
WeighScore62.5/10059.7/100
GradeCC
Scorecard rank#267#337
SemaglutideNot disclosed$199/mo (starting dose, compounded)
TirzepatideNot disclosed$199/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
JRNYS

Graded #267 · C

Strengths

  • Branded, FDA-approved GLP-1s — Wegovy, Ozempic, Zepbound, Mounjaro and Saxenda — rather than compounded copies
  • The membership band is published before intake and is banded openly by level of coach support
  • Medical visits, daily monitoring and 1-on-1 coaching are included in the membership at every tier
  • Led by CMO Dr. Henry Legere (UC Berkeley, Columbia medicine, Harvard fellowship)
  • Members with commercial insurance may pay around $25 a month for the medication after any deductible

Where it loses points

  • The membership is overhead, not a medication price: it covers visits, monitoring and coaching, and the FAQ says medication pricing is confirmed only after a provider consultation
  • No self-pay drug price is published anywhere, so the cost of a month cannot be worked out before signing up
  • The best case depends on commercial insurance coverage; without it the medication cost is unknown
  • No compounded option is disclosed — the programme is brand-focused, and brand list prices are the dearest route to a GLP-1
  • The states it can prescribe in are not published
Vitalex Health

Graded #337 · C

Strengths

  • Flat-rate pricing starting at $199/mo with no consultation fee or dose-change surcharges
  • Three distinct programs — Semaglutide, Tirzepatide, and a lower-dose GLP-1 Microdose protocol for body composition
  • Names its legal entity (Vitalex Health, LLC), a real street address, phone number, and posted clinical hours
  • Named lead clinician (Laqueta Nelson, MSN, FNP-BC) instead of an anonymous care team
  • Working Terms of Service, Privacy Policy, and HIPAA Notice pages, not dead links

Where it loses points

  • Brands itself “physician-led” sitewide, but the only named clinician is a nurse practitioner (FNP-BC), not a physician
  • No LegitScript seal or other third-party pharmacy-verification badge found anywhere on the site
  • Compounding pharmacy and prescribing medical group are referenced only generically — neither is named
  • Exact price is not published — the $199/mo figure is only a starting point confirmed after provider review
  • Domain was registered in April 2026 — a brand-new practice with no independent reviews found

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard